Cambridge Investment Research Advisors, Inc. Catalent, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $27.1 Billion
- Q2 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 7,670 shares of CTLT stock, worth $463,344. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,670
Previous 59,452
87.1%
Holding current value
$463,344
Previous $3.36 Million
87.16%
% of portfolio
0.0%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding CTLT
# of Institutions
489Shares Held
165MCall Options Held
364KPut Options Held
837K-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.23 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$928 Million0.02% of portfolio
-
Nomura Holdings Inc Tokyo, M011MShares$664 Million1.22% of portfolio
-
State Street Corp Boston, MA7.34MShares$443 Million0.02% of portfolio
-
Barclays PLC London, X04.97MShares$300 Million0.09% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.9B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...